Feb 25, 2011
More than 400 drugs are in late-stage clinical development or awaiting...
WASHINGTON — More than 400 drugs are in late-stage clinical...
more
Feb 25, 2011
The Food and Drug Administration has declined to approve a biologic...
KARMIEL, Israel — The Food and Drug Administration has declined to...
more
Feb 24, 2011
Generic drug maker Par Pharmaceutical Cos. had sales of $227 million...
WOODCLIFF LAKE, N.J. — Generic drug maker Par Pharmaceutical Cos....
more
Feb 24, 2011
Novo Nordisk has filed for approval of a treatment for a rare genetic...
PRINCETON, N.J. — Novo Nordisk has filed for approval of a treatment...
more
Feb 24, 2011
Drug maker Takeda has filed for regulatory approval of a drug to treat...
OSAKA, Japan — Drug maker Takeda has filed for regulatory approval...
more
Feb 23, 2011
Drug maker Forest Labs plans to acquire the developer of a recently...
NEW YORK — Drug maker Forest Labs plans to acquire the developer of...
more
Feb 23, 2011
The makers behind a popular Type 2 diabetes treatment have included data...
PRINCETON, N.J., and WILMINGTON, Del. — The makers behind a popular...
more
Get the latest news in retail health with the DSN Collaborative Care E-Newsletter. Product news, clinical updates, patient health information — everything you need to stay on top of your industry.
